Comparison of Propofol-Fentanyl and Propofol-Dexmedetomidine combinations for sedation in ERCP
Not Applicable
Completed
- Conditions
- Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere
- Registration Number
- CTRI/2023/06/054292
- Lead Sponsor
- WASIM WAHID
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 81
Inclusion Criteria
Patient undergoing ERCP under iv sedation
1)ASA physical status I,II and III
2)Body weight :40 to 70 kg
Exclusion Criteria
1)Allergy or history of adverse reaction to Propofol, Dexmedetomidine or Fentanyl
2)Pregnancy or lactation
3)Anticipated difficult airway
4)Patients with chronic kidney disease, neurological deficit, pre-existing delirium/cognitive dysfunction
5)Evidence of hepatic encephalopathy or ascites
6)Hyponatremia ( <120 meq/l) and hypo or hyperkalemia ( <3meq/l and >5.5 meq/l)
7)Patient refusal
8)Patients with comorbidities like uncontrolled hypertension, hypotension, uncontrolled diabetes mellitus, congestive cardiac failure, and low cardiac output disorders or arrhythmias.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method